Literature DB >> 15740597

How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches.

T Biró1, M C Ko, B Bromm, E T Wei, P Bigliardi, F Siebenhaar, H Hashizume, L Misery, N V Bergasa, C Kamei, J Schouenborg, D Roostermann, T Szabó, M Maurer, M Bigliardi-Qi, J G Meingassner, M A Hossen, M Schmelz, M Steinhoff.   

Abstract

While the enormous clinical and psychosocial importance of pruritus in many areas of medicine and the detrimental effects of chronic 'itch' on the quality of life of an affected individual are widely appreciated, the complexity of this sensation is still often grossly underestimated. The current Controversies feature highlights this complexity by portraying pruritus as a truly interdisciplinary problem at the crossroads of neurophysiology, neuroimmunology, neuropharmacology, protease research, internal medicine, and dermatology, which is combated most successfully if one keeps the multilayered nature of 'itch' in mind and adopts a holistic treatment approach - beyond the customary, frequently frustrane monotherapy with histamine receptor antagonists. In view of the often unsatisfactory, unidimensional, and altogether rather crude standard instruments for pruritus management that we still tend to use in clinical practice today, an interdisciplinary team of pruritus experts here critically examines recent progress in pruritus research that future itch management must take into consideration. Focusing on new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus, and discussing available neuropharmacological tools, specific research avenues are highlighted, whose pursuit promises to lead to novel, and hopefully more effective, forms of pruritus management.

Entities:  

Mesh:

Year:  2005        PMID: 15740597     DOI: 10.1111/j.0906-6705.2005.0321a.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  14 in total

1.  Effects of butorphanol on morphine-induced itch and analgesia in primates.

Authors:  Heeseung Lee; Norah N Naughton; James H Woods; Mei-Chuan Ko
Journal:  Anesthesiology       Date:  2007-09       Impact factor: 7.892

2.  Icilin-evoked behavioral stimulation is attenuated by alpha₂-adrenoceptor activation.

Authors:  Jae Kim; Alan Cowan; Renata Lisek; Natalie Raymondi; Aaron Rosenthal; Daniel D Hirsch; Scott M Rawls
Journal:  Brain Res       Date:  2011-04-12       Impact factor: 3.252

Review 3.  Frontiers in pruritus research: scratching the brain for more effective itch therapy.

Authors:  Ralf Paus; Martin Schmelz; Tamás Bíró; Martin Steinhoff
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

4.  Nalfurafine, the kappa opioid agonist, inhibits icilin-induced wet-dog shakes in rats and antagonizes glutamate release in the dorsal striatum.

Authors:  Jennifer L Werkheiser; Scott M Rawls; Alan Cowan
Journal:  Neuropharmacology       Date:  2006-12-05       Impact factor: 5.250

5.  Effects of virtual reality immersion and audiovisual distraction techniques for patients with pruritus.

Authors:  Vera Leibovici; Florella Magora; Sarale Cohen; Arieh Ingber
Journal:  Pain Res Manag       Date:  2009 Jul-Aug       Impact factor: 3.037

6.  The association between anxiety sensitivity and atopy in adult asthmatics.

Authors:  Silvana Barone; Simon L Bacon; Tavis S Campbell; Manon Labrecque; Blaine Ditto; Kim L Lavoie
Journal:  J Behav Med       Date:  2008-07-09

Review 7.  Neuropathic pruritus.

Authors:  Laurent Misery; Emilie Brenaut; Raphaële Le Garrec; Claire Abasq; Steeve Genestet; Pascale Marcorelles; Fabien Zagnoli
Journal:  Nat Rev Neurol       Date:  2014-06-10       Impact factor: 42.937

8.  Spinal Functions of B-Type Natriuretic Peptide, Gastrin-Releasing Peptide, and Their Cognate Receptors for Regulating Itch in Mice.

Authors:  Norikazu Kiguchi; Devki D Sukhtankar; Huiping Ding; Ken-ichi Tanaka; Shiroh Kishioka; Christopher M Peters; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2015-12-15       Impact factor: 4.030

9.  Tonic inhibition of TRPV3 by Mg2+ in mouse epidermal keratinocytes.

Authors:  Jialie Luo; Randi Stewart; Rebecca Berdeaux; Hongzhen Hu
Journal:  J Invest Dermatol       Date:  2012-05-24       Impact factor: 8.551

10.  Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis.

Authors:  Audra L Clos; Rakez Kayed; Cristian A Lasagna-Reeves
Journal:  Front Neurol       Date:  2012-01-20       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.